The Medicines Company

Part of Novartis

CompanyUnited StatesFounded 1996

Wikidata

The Medicines Company develops one asset, approved (inclisiran in hypercholesterolemia). Mostly oligonucleotide acting on PCSK9; based in the United States, founded in 1996.

1
Asset
Furthest stage
Approved
23
Trials
75
Signals

Pipeline

1
  • inclisiran

    Silences hepatic PCSK9 expression, increasing LDL receptor recycling and lowering circulating LDL cholesterol.

    Approved, Oligonucleotide, PCSK9, hypercholesterolemia, heterozygous familial hypercholesterolemia

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Evidence behind the mechanisms2
  • Trials25
  • Signals20
  • Similar companies6

Intelligence